Postbariatric Hypoglycemia
2 competing products in clinical development for Postbariatric Hypoglycemia.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| MBX 1416 (INN imapextide) | MBX Biosciences | Phase 2 | Recruiting | 47 |
| MBX 1416 (Part A) + MBX 1416 (Part B) + Placebo + MBX 1416 (Part C) | MBX Biosciences | Phase 1 | Completed | 28 |